treatment of npm1-mutated aml: intensive standard treatment
Published 4 years ago • 1K plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
2:43
venetoclax and intensive chemotherapy in npm1-mutated aml: findings from the caveat study
-
1:52
aml19 update: improvement in os in patients with npm1-mutated aml treated with flag-ida-go
-
1:53
treatment strategies for patients with idh1/2-mutated aml ineligible for intensive chemotherapy
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
2:32
how quickly does aml progress? #aml
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
4:34
the genetics of acute myeloid leukemia (aml)
-
1:11
the treatment of aml within the united kingdom nhs framework
-
1:45
the impact of secondary-type mutations in npm1-mutated aml
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
1:38
value of mrd in patients with npm1-mutated aml
-
1:38
lba: komet-001 - ziftomenib monotherapy in r/r npm1-mutated aml
-
2:36
intensive induction chemotherapy vs hma/ven in npm1-mutant aml: a retrospective study
-
3:05
mrd negativity assessed by flow cytometry associated with improved outcomes in npm1-mutated aml
-
1:21
intensive therapy of older aml
-
1:56
mrd negativity in npm1-mutated aml: the influence of co-occurring mutations and flag-ida induction
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
1:40
the role of menin inhibitors in the treatment of aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:09
advances in the management of fit adults with aml